Sushma Shivaswamy, Ph.D.
Chief Scientific Officer
Dr. Shivaswamy was appointed as the Company’s Chief Scientific Officer in November 2017. As CSO Dr. Shivaswamy oversees all scientific and technical operations with respect to research and development and GMP production of antibody. Dr. Shivaswamy has previously served as the Company’s Vice President of Research and Development since January 2015 where she led teams involved in various Research & Development projects at XBiotech including Antibody Discovery, Cell Line Development, and pre-clinical toxicology and efficacy studies using animal models. Dr. Shivaswamy has been with the Company since 2009 also holding positions of Director of Research & Development (2011-2015) and Senior Scientist (2009-2011). Prior to joining XBiotech, Dr. Shivaswamy was a postdoctoral researcher at the Center for Systems and Synthetic Biology at the University of Texas at Austin. She has a Ph.D. degree in Molecular Biology from the Center for Cellular and Molecular Biology, India. Dr. Shivaswamy’s academic studies have involved elucidating mechanisms for regulation of gene expression.